Related Experiment Video
Updated: Jan 3, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Pathophysiology of Aortic Stenosis and Future Perspectives for Medical Therapy
Kang H Zheng1, Evangelos Tzolos2, Marc R Dweck2
1Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Insights
Calcific aortic valve stenosis is a growing health burden with no current medical treatments. This review explores new therapeutic targets like oxidized lipids, fibrosis, and calcification to slow disease progression.
Area of Science:
- Cardiovascular Medicine
- Valvular Heart Disease
- Biomedical Research
Background:
- Calcific aortic valve stenosis (CAVS) is the most prevalent heart valve disease in high-income nations.
- Current treatment options for CAVS are limited to surgical aortic valve replacement, with uncertain optimal timing and patient suitability.
- There is a significant unmet need for medical therapies to slow or halt the progression of CAVS.
Purpose of the Study:
- To review the pathophysiology of aortic stenosis.
- To discuss the role of noninvasive imaging in understanding CAVS biology.
- To explore potential novel therapeutic strategies targeting key molecular pathways in CAVS.
Main Methods:
- Literature review of pathophysiology and imaging techniques in aortic stenosis.
- Analysis of emerging insights into the biological mechanisms of CAVS.
- Discussion of potential translation of research findings into clinical treatments.
Main Results:
- Aortic stenosis pathophysiology involves complex biological processes.
- Noninvasive imaging has enhanced the understanding of underlying CAVS biology.
- Emerging research identifies oxidized lipids, fibrosis, and calcification as potential therapeutic targets.
Conclusions:
- Novel therapeutic approaches targeting specific molecular pathways may offer future treatment options for CAVS.
- Further research is needed to translate these insights into effective medical therapies.
- Addressing the burden of CAVS requires innovative treatment strategies beyond surgical intervention.
Abstract:
Calcific aortic valve stenosis is the commonest form of heart valve disease in high-income countries and set to become a major health care burden. Currently, there are no medical therapies that have proved to slow down or halt disease progression. The only available treatment is aortic valve replacement, of which the optimal timing is unknown and to which not all patients are suited. This review discusses the pathophysiology of aortic stenosis, how noninvasive imaging techniques have improved our understanding of the underlying biology, and how these emerging insights might translate into potential novel treatments targeting oxidized lipids, fibrosis, and calcification.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation IV: Nursing Management

